Literature DB >> 19020160

Bupivacaine infusion above or below the fascia for postoperative pain treatment after abdominal hysterectomy.

Meltem Cakmak Hafizoglu1, Kaan Katircioglu, Murat Y Ozkalkanli, Serdar Savaci.   

Abstract

BACKGROUND: We evaluated in which anatomic layer (above the fascia [AF] or below the fascia [BF]) wound infusion of bupivacaine has the best effect on postoperative pain after abdominal hysterectomy.
METHODS: Sixty-two ASA physical status I and II patients undergoing total abdominal hysterectomy and bilateral salpingo-oophorectomy were enrolled into this prospective randomized, double-blind study. A standard general anesthetic was administered. On completion of the operation, a multiorifice 20-gauge epidural catheter was placed above (group AF, n = 29) or below (group BF, n = 31) the superficial abdominal fascia and 0.25% bupivacaine was administered via a patient-controlled analgesia device, programmed to deliver 9.0 mL with a 60-min lockout interval for 24 h. During the first 6 h after surgery, rescue i.v. fentanyl (25 microg) was administered to achieve a visual analog scale score of <4 cm. Total bupivacaine consumption, total rescue fentanyl consumption, pain scores (with resting, coughing, and leg raising), and patient satisfaction scores were compared in both groups.
RESULTS: Total bupivacaine consumption over 24 h was significantly lower in group AF rather than group BF (90 +/- 26 mL vs 104 +/- 28 mL, respectively, P < 0.05). The total fentanyl consumption during the first 6 h after surgery was 109 +/- 59 microg in group AF and 166 +/- 70 microg in group BF (P < 0.01). Pain scores were lower in group AF at rest and coughing for the first 5 h and for the first 12 h with leg raise (P < 0.05 for all measurements). Thirteen patients (68%) in group AF defined their satisfaction as excellent whereas six patients (32%) in group BF defined their satisfaction as excellent (P = 0.034).
CONCLUSION: We conclude that bupivacaine wound infusion AF provides better postoperative analgesia compared with infusion BF in the first 12 h after abdominal hysterectomy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020160     DOI: 10.1213/ane.0b013e318187ed23

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  The efficacy of continuous subcostal transversus abdominis plane block for analgesia after living liver donation: a retrospective study.

Authors:  Akihiko Maeda; Sho Carl Shibata; Hiroshi Wada; Shigeru Marubashi; Takahiko Kamibayashi; Hidetoshi Eguchi; Yuji Fujino
Journal:  J Anesth       Date:  2015-10-28       Impact factor: 2.078

2.  Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part II.

Authors:  G Nelson; A D Altman; A Nick; L A Meyer; P T Ramirez; C Achtari; J Antrobus; J Huang; M Scott; L Wijk; N Acheson; O Ljungqvist; S C Dowdy
Journal:  Gynecol Oncol       Date:  2016-01-03       Impact factor: 5.482

3.  Continuous wound infiltration of bupivacaine at two different anatomical planes for caesarean analgesia - A randomised clinical trial.

Authors:  Diana Thomas; Sakthirajan Panneerselvam; Pankaj Kundra; Priya Rudingwa; Ranjith K Sivakumar; Gowri Dorairajan
Journal:  Indian J Anaesth       Date:  2019-06

4.  The pharmacokinetics and safety of an intraoperative bupivacaine-collagen implant (XaraColl(®)) for postoperative analgesia in women following total abdominal hysterectomy.

Authors:  Susan L Cusack; Philip Reginald; Lisa Hemsen; Emmanuel Umerah
Journal:  J Pain Res       Date:  2013-03-04       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.